巨化股份 reported revenue of ¥13.34B for the period ended 2026-06-30, +0.1% year on year. Net income was ¥2.98B, a 22.3% net margin on a 34.0% gross margin. The largest revenue line is 制冷剂 at 51% of the total. Free cash flow for the period was ¥-0.59B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥13.34B | +0.1% |
| Gross profit | ¥4.54B | — |
| Operating income | ¥3.44B | — |
| Net income | ¥2.98B | +30.8% |
| Gross margin | 34.0% | Net margin 22.3% |
| Revenue Q/Q | +21.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 制冷剂 | ¥6.75B | 50.6% |
| 石化材料 | ¥1.65B | 12.4% |
| 基础化工产品及其它 | ¥1.43B | 10.7% |
| 含氟聚合物材料 | ¥1.16B | 8.7% |
| 其他 | ¥1.01B | 7.6% |
| 氟化工原料 | ¥0.60B | 4.5% |
| 食品包装材料 | ¥0.42B | 3.1% |
| 含氟精细化学品 | ¥0.28B | 2.1% |
| 检维修及工程管理 | ¥0.02B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥8.80B | 66.0% |
| R&D | ¥0.51B | 3.9% |
| SG&A | ¥0.42B | 3.2% |
| Tax & other | ¥0.46B | 3.5% |
| Item | Amount |
|---|---|
| Total assets | ¥41.43B |
| Total liabilities | ¥16.02B |
| Shareholders' equity | ¥25.41B |
| Equity / assets | 61.3% |
| Operating cash flow | ¥1.39B |
| Capital expenditure | ¥1.98B |
| Free cash flow | ¥-0.59B |
| Cash conversion (OCF / net income) | 78% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中国巨石 ・ 生益科技 ・ 兖矿能源 ・ 复星医药 ・ 南山铝业 ・ 海航控股 ・ 圆通速递 ・ 恒瑞医药 ・ 万华化学 ・ 恒力石化 ・ 江西铜业 ・ 中航机载
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies